Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Clinical trial NCT03093870 · COMPLETED
Trial details
- NCT number
- NCT03093870
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-04
- Primary completion
- 2019-11-12
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.